Appian Aktie
Appian Aktie
Was spricht für und gegen Appian in den nächsten Jahren?
Pro
Kontra
Rendite von Appian im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Appian | -1,74 % | 11,97 % | 16,72 % | -3,39 % | -22,84 % | -50,12 % | -76,16 % |
| Asure Software | -0,69 % | 9,92 % | 4,35 % | -14,29 % | -8,86 % | -40,98 % | -8,86 % |
| Mitek Systems Inc. | 0,07 % | -2,36 % | -17,82 % | 83,41 % | 61,79 % | 55,87 % | -22,40 % |
| Netsol Technologies | -2,66 % | -4,19 % | -8,96 % | 7,02 % | 42,97 % | 79,41 % | -0,54 % |
Kommentare
News
Stock Market Today, July 21: UiPath Falls 1% Despite Tech Stock Rebound
UiPath (NYSE:PATH), an artificial intelligence (AI) robotic and automation software provider, closed at $12.04, down 0.99%. Recent investment reports that put the spotlight on UiPath's customer
Stock Market Today, July 17: UiPath Gains on Retail AI Partnership
UiPath (NYSE:PATH), an enterprise automation and robotic software provider, closed at $12.15, up 1.00%. The gains follow a recent retail artificial intelligence (AI) partnership, while broader
What Does Appian CEO's Sale of 50,000 Shares for $1.2 Million Mean for Investors?
Matthew W. Calkins, CEO and founder of Appian (NASDAQ:APPN), reported an open-market sale of 50,000 shares for a total of approximately $1.21 million on June 8, 2026, according to a SEC Form 4



